Raaj Medisafe India Limited has reported a robust financial performance for the quarter, marked by significant revenue growth and the successful launch of a new hygiene segment. The company's strategic diversification and strong execution have yielded impressive results across key financial metrics.

Financial Highlights

• Revenue Growth: The company's revenue soared by 45.10% to ₹158.27 crores, compared to ₹109.06 crores in the same quarter of the previous year.
• Net Profit: Net profit saw a substantial increase of 50.00%, reaching ₹14.61 crores, up from ₹9.74 crores in the corresponding quarter.
• EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew by 51.60% to ₹26.28 crores, with the EBITDA margin improving to 16.60% from 15.90% year-over-year.
• Earnings Per Share (EPS): EPS rose to ₹1.11 from ₹0.74 in the same quarter last year.

Segment Performance

The company's performance was bolstered by its two main segments:

Hygiene Segment

• Newly launched segment producing sanitary napkins and diapers
• Contributed ₹42.29 crores, accounting for 26.70% of total revenue
• Achieved an EBIT margin of 18.30%

Plastic Segment

• Grew by 6.60% to ₹116.26 crores
• EBIT margin improved significantly to 15.30% from 10.50% in the previous year

Balance Sheet Strength

• Total Assets: Grew by 18.10% to ₹817.71 crores
• Debt-to-Equity Ratio: Stood at 2.04

Management Commentary

Arpit Bangur, Chairman and Managing Director of Raaj Medisafe India Limited, stated, "Our strong performance this quarter reflects the success of our diversification strategy and operational excellence. The new hygiene segment has exceeded our expectations, contributing significantly to our overall growth. We remain committed to innovation and expanding our product portfolio to meet evolving consumer needs."

Corporate Updates

In addition to the financial results, the company announced several key corporate updates:

1. Appointment of CFO: Ms. Fatima Dadani, a Chartered Accountant with over 7 years of professional experience, has been appointed as the new Chief Financial Officer effective August 11, 2025.

2. Auditor Appointments:

   • M/s. M Maheshwari & Associates have been appointed as Secretarial Auditors for a five-year term (2025-26 to 2029-30).
   • M/s. GDK & Associates are proposed to be appointed as Statutory Auditors, subject to approval at the upcoming Annual General Meeting.

3. Annual General Meeting: The 40th Annual General Meeting is scheduled for September 25, 2025, to be held via video conferencing.

Raaj Medisafe India Limited's strong quarterly performance, coupled with strategic appointments and expansion into the hygiene segment, positions the company for continued growth. Investors and stakeholders will be keenly watching how the company leverages its new segment and maintains its growth trajectory in the competitive market landscape.

Raaj Medisafe India Limited , a leading manufacturer in the plastic and hygiene products sector, has announced several key decisions following its board meeting on August 11, 2025. The company has made significant appointments and set important dates for its upcoming Annual General Meeting (AGM).

New Chief Financial Officer

Ms. Fatima Dadani, a Chartered Accountant with over seven years of professional experience, has been appointed as the new Chief Financial Officer (CFO) of Raaj Medisafe India Limited, effective August 11, 2025. Ms. Dadani brings a wealth of expertise in financial operations across service and manufacturing sectors, with core competencies in financial reporting, budgeting, compliance, and SAP implementation.

Auditor Appointments

The board has proposed the appointment of new auditors, subject to approval at the upcoming AGM:

• Statutory Auditors: M/s. GDK & Associates, Chartered Accountants, Indore
• Secretarial Auditors: M/s. M Maheshwari & Associates, Practicing Company Secretaries, Indore
• Internal Auditors: M/s. Arpit Gaur & Company for the financial year 2025-26

These appointments are proposed for a five-year term from 2025-26 to 2029-30, highlighting the company's commitment to maintaining robust financial and regulatory compliance.

40th Annual General Meeting

The company has scheduled its 40th Annual General Meeting for September 25, 2025, to be held via video conferencing. Key dates related to the AGM include:

Shri Manish Maheshwar of M. Maheshwari & Associates, Company Secretaries, has been appointed as the scrutinizer for the e-voting process.

Financial Results

The board has approved the unaudited financial results for the quarter ended June 30, 2025. While specific figures were not disclosed in the main announcement, the approval of these results indicates the company's adherence to regulatory requirements and commitment to transparency.

Corporate Governance

The board has taken on record various reports for the quarter ended June 30, 2025, including the Statement of Investors Complaints, Shareholding Pattern, Integrated Corporate Governance Report, and the Secretarial Compliance Report for the year ended March 31, 2025. These actions underscore Raaj Medisafe India's dedication to maintaining high standards of corporate governance and investor relations.

The comprehensive decisions made during this board meeting reflect Raaj Medisafe India Limited's focus on strengthening its financial leadership, ensuring regulatory compliance, and maintaining transparent communication with its shareholders. As the company prepares for its 40th AGM, these strategic moves position it for continued growth and stability in the plastic and hygiene products industry.